AAAAAA
Results:
1-20
|
Results: 20
Authors:
NAKAZI M
BAUER U
KATHMANN M
GOTHERT M
SCHLICKER E
Citation: M. Nakazi et al., THE STEREOSELECTIVE KAPPA-OPIOID RECEPTOR ANTAGONIST MR-2266 DOES NOTEXHIBIT STEREOSELECTIVITY AS AN ANTAGONIST AT ORPHAN OPIOID (ORL1) RECEPTORS, Naunyn-Schmiedeberg's archives of pharmacology, 358(4), 1998, pp. 96-96
Authors:
SCHLICKER E
WERTHWEIN S
KATHMANN M
BAUER U
Citation: E. Schlicker et al., NOCICEPTIN INHIBITS NORADRENALINE RELEASE IN THE MOUSE-BRAIN CORTEX VIA PRESYNAPTIC ORL1 RECEPTORS, Naunyn-Schmiedeberg's archives of pharmacology, 358(4), 1998, pp. 418-422
Authors:
KATHMANN M
GOTHERT M
SCHLICKER E
Citation: M. Kathmann et al., ANTISENSE OLIGODEOXYNUCLEOTIDES DECREASE DENSITY OF CB1 CANNABINOID RECEPTORS IN RAT HIPPOCAMPUS AND STRIATUM, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 309-309
Authors:
WERTHWEIN S
BAUER U
KATHMANN M
SCHLICKER E
Citation: S. Werthwein et al., NOCICEPTIN INHIBITS NORADRENALINE RELEASE IN THE MOUSE-BRAIN CORTEX VIA PRESYNAPTIC ORPHAN OPIOID RECEPTORS, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 1322-1322
Authors:
KATHMANN M
SCHLICKER E
GOTHERT M
Citation: M. Kathmann et al., NMDA-STIMULATED AND KAINATE-STIMULATED NORADRENALINE RELEASE IN THE GUINEA-PIG HIPPOCAMPUS IS MODULATED BY CANNABINOID CB1 RECEPTORS, Naunyn-Schmiedeberg's archives of pharmacology, 357(4), 1998, pp. 345-345
Authors:
SCHLICKER E
WERTHWEIN S
KATHMANN M
Citation: E. Schlicker et al., ORPHAN OPIOID RECEPTOR-MEDIATED INHIBITION OF NORADRENALINE, DOPAMINEAND SEROTONIN RELEASE IN THE MOUSE, RAT AND GUINEA-PIG BRAIN, Naunyn-Schmiedeberg's archives of pharmacology, 357(4), 1998, pp. 348-348
Authors:
SCHLICKER E
FINK K
KATHMANN M
MOLDERINGS GJ
GOTHERT M
Citation: E. Schlicker et al., EFFECTS OF IMIDAZOLINES ON NORADRENALINE RELEASE IN BRAIN - AN INVESTIGATION INTO THEIR RELATIONSHIP TO IMIDAZOLINE, ALPHA(2) AND H-3 RECEPTORS, Neurochemistry international, 30(1), 1997, pp. 73-83
Authors:
SCHLICKER E
KATHMANN M
BITSCHNAU H
MARR I
REIDEMEISTER S
STARK H
SCHUNACK W
Citation: E. Schlicker et al., POTENCIES OF ANTAGONISTS CHEMICALLY RELATED TO IODOPROXYFAN AT HISTAMINE H-3 RECEPTORS IN MOUSE-BRAIN CORTEX AND GUINEA-PIG ILEUM - EVIDENCE FOR H-3 RECEPTOR HETEROGENEITY, Naunyn-Schmiedeberg's archives of pharmacology, 353(5), 1996, pp. 482-488
Authors:
LEURS R
KATHMANN M
VOLLINGA RC
MENGE WMPB
SCHLICKER E
TIMMERMAN H
Citation: R. Leurs et al., HISTAMINE HOMOLOGS DISCRIMINATING BETWEEN 2 FUNCTIONAL H-3 RECEPTOR ASSAYS - EVIDENCE FOR H-3 RECEPTOR HETEROGENEITY, The Journal of pharmacology and experimental therapeutics, 276(3), 1996, pp. 1009-1015
Authors:
DRUTEL G
KATHMANN M
HERON A
SCHWARTZ JC
ARRANG JM
Citation: G. Drutel et al., CLONING AND SELECTIVE EXPRESSION IN BRAIN AND KIDNEY OF ARNT2 HOMOLOGOUS TO THE AH RECEPTOR NUCLEAR TRANSLOCATOR (ARNT), Biochemical and biophysical research communications, 225(2), 1996, pp. 333-339
Authors:
SCHLICKER E
PERTZ H
BITSCHNAU H
PURAND K
KATHMANN M
ELZ S
SCHUNACK W
Citation: E. Schlicker et al., EFFECTS OF IODOPROXYFAN, A POTENT AND SELECTIVE HISTAMINE H-3 RECEPTOR ANTAGONIST, ON ALPHA(2) AND 5-HT3 RECEPTORS, Inflammation research, 44(7), 1995, pp. 296-300
Authors:
KATHMANN M
SCHLICKER E
GOTHERT M
Citation: M. Kathmann et al., INTERMEDIATE AFFINITY AND POTENCY OF CLOZAPINE AND LOW-AFFINITY OF OTHER NEUROLEPTICS AND OF ANTIDEPRESSANTS AT H-3 RECEPTORS, Psychopharmacology, 116(4), 1994, pp. 464-468
Authors:
SCHLICKER E
MALINOWSKA B
KATHMANN M
GOTHERT M
Citation: E. Schlicker et al., MODULATION OF NEUROTRANSMITTER RELEASE VIA HISTAMINE H-3 HETERORECEPTORS, Fundamental and clinical pharmacology, 8(2), 1994, pp. 128-137
Authors:
DETZNER M
KATHMANN M
SCHLICKER E
Citation: M. Detzner et al., TIME-COURSE OF THE EFFECTS OF HISTAMINE, THIOPERAMIDE AND EEDQ ON H-3RECEPTORS IN THE MOUSE-BRAIN, Agents and actions, 41, 1994, pp. 30000066-30000067
Authors:
SCHLICKER E
KATHMANN M
DETZNER M
EXNER HJ
GOTHERT M
Citation: E. Schlicker et al., H-3 RECEPTOR-MEDIATED INHIBITION OF NORADRENALINE RELEASE - AN INVESTIGATION INTO THE INVOLVEMENT OF CA2-PROTEIN AND ADENYLATE-CYCLASE( ANDK+ IONS, G), Naunyn-Schmiedeberg's archives of pharmacology, 350(1), 1994, pp. 34-41
Authors:
SCHLICKER E
KATHMANN M
EXNER HJ
DETZNER M
GOTHERT M
Citation: E. Schlicker et al., THE 5-HT3 RECEPTOR AGONIST 1-(M-CHLOROPHENYL)-BIGUANIDE FACILITATES NORADRENALINE RELEASE BY BLOCKADE OF ALPHA(2)-ADRENOCEPTORS IN THE MOUSE-BRAIN CORTEX, Naunyn-Schmiedeberg's archives of pharmacology, 349(1), 1994, pp. 20-24
Authors:
SCHLICKER E
KATHMANN M
REIDEMEISTER S
STARK H
SCHUNACK W
Citation: E. Schlicker et al., NOVEL HISTAMINE H-3 RECEPTOR ANTAGONISTS - AFFINITIES IN AN H-3 RECEPTOR-BINDING ASSAY AND POTENCIES IN 2 FUNCTIONAL H-3 RECEPTOR MODELS (VOL 112, PG 1043, 1994), British Journal of Pharmacology, 113(2), 1994, pp. 657-657
Authors:
SCHLICKER E
KATHMANN M
REIDEMEISTER S
STARK H
SCHUNACK W
Citation: E. Schlicker et al., NOVEL HISTAMINE-H-3 RECEPTOR ANTAGONISTS - AFFINITIES IN AN H-3 RECEPTOR-BINDING ASSAY AND POTENCIES IN 2 FUNCTIONAL H-3 RECEPTOR MODELS, British Journal of Pharmacology, 112(4), 1994, pp. 1043-1048
Authors:
SCHLICKER E
MALINOWSKA B
KATHMANN M
Citation: E. Schlicker et al., CGP-35348 BLOCKS NORADRENALINE-RELEASE-INHIBITING GABA(B) RECEPTORS IN THE PIG RETINA, RAT VENA-CAVA AND PITHED RAT VASCULATURE, Pharmacology, 47(2), 1993, pp. 111-116
Authors:
KATHMANN M
SCHLICKER E
DETZNER M
TIMMERMAN H
Citation: M. Kathmann et al., NORDIMAPRIT, HOMODIMAPRIT, CLOBENPROPIT AND IMETIT - AFFINITIES FOR H-3 BINDING-SITES AND POTENCIES IN A FUNCTIONAL H-3 RECEPTOR MODEL, Naunyn-Schmiedeberg's archives of pharmacology, 348(5), 1993, pp. 498-503
Risultati:
1-20
|